Compounds > fluorexon
Page last updated: 2024-08-24

fluorexon and Breast Neoplasms

fluorexon has been researched along with Breast Neoplasms in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (15.38)29.6817
2010's10 (76.92)24.3611
2020's1 (7.69)2.80

Authors

AuthorsStudies
Abuwatfa, W; Ajith, S; Al-Sayah, MH; Awad, N; Elamir, A; Husseini, GA; Mukhopadhyay, D; Paul, V; Sawaftah, NA1
Al Sayah, M; Husseini, GA; Kawak, P; Martins, AM; Paul, V; Salkho, NM; Vitor, RF1
Al-Sayah, MH; Awad, NS; Husseini, GA; Paul, V1
Banerjee, R; De, A; Jagtap, M; Rengan, AK; Srivastava, R1
Chowdhury, P; Lin, FT; Lin, GE; Lin, WC; Liu, K; Song, Y1
Blumenthal, R; Charron, H; Joshi, A; Puri, A; Schiff, R; Sine, J; Tata, DB; Thayer, D; Urban, C; Valim, N1
Fukuda, H; Hwang, SY; Kondo, A; Mieda, H; Nishimura, Y; Ogino, C; Shishido, T; Tanaka, T1
Chiu, W; Goodwin, JT; Khant, HA; Li, F; Li, KC; Li, Z; O'Neill, BE; Qin, G; Xia, R1
Chen, HY; Hsu, CY; Huang, FH; Huang, LY; Lai, PS; Shieh, MJ1
Arbuzova, A; Brodersen, N; Budde, B; Egger, H; Goldenbogen, B; Gramatica, A; Herrmann, A; Liebscher, J; Loew, M1
Anchordoquy, TJ; Kullberg, M; Mann, K1
Barrand, MA; Cahn, AP; Cooray, HC; Hladky, SB; Shahi, S; van Veen, HW1
Arndt, D; Fahr, A; Maurer, N; Müller, K; Zeisig, R1

Other Studies

13 other study(ies) available for fluorexon and Breast Neoplasms

ArticleYear
Ultrasound-triggered herceptin liposomes for breast cancer therapy.
    Scientific reports, 2021, 04-06, Volume: 11, Issue:1

    Topics: Antibodies, Monoclonal; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Doxorubicin; Drug Delivery Systems; Drug Liberation; Female; Fluoresceins; Humans; Immunoconjugates; Liposomes; Receptor, ErbB-2; Trastuzumab; Ultrasonic Therapy

2021
Ultrasonically controlled estrone-modified liposomes for estrogen-positive breast cancer therapy.
    Artificial cells, nanomedicine, and biotechnology, 2018, Volume: 46, Issue:sup2

    Topics: Biological Transport; Breast Neoplasms; Doxorubicin; Drug Liberation; Estrogens; Estrone; Fluoresceins; Humans; Liposomes; MCF-7 Cells; Particle Size; Ultrasonic Waves

2018
Ultrasonically controlled albumin-conjugated liposomes for breast cancer therapy.
    Artificial cells, nanomedicine, and biotechnology, 2019, Volume: 47, Issue:1

    Topics: Breast Neoplasms; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Drug Liberation; Fluoresceins; Humans; Liposomes; Polyethylene Glycols; Serum Albumin, Human; Ultrasonic Waves

2019
Multifunctional gold coated thermo-sensitive liposomes for multimodal imaging and photo-thermal therapy of breast cancer cells.
    Nanoscale, 2014, Jan-21, Volume: 6, Issue:2

    Topics: Breast Neoplasms; Cell Line, Tumor; Cell Survival; Contrast Media; Female; Fluoresceins; Gold; Humans; Infrared Rays; Liposomes; Metal Nanoparticles; Particle Size; Phototherapy; Tomography, X-Ray Computed

2014
Targeting TopBP1 at a convergent point of multiple oncogenic pathways for cancer therapy.
    Nature communications, 2014, Nov-17, Volume: 5

    Topics: Animals; Apoptosis; Breast Neoplasms; Carrier Proteins; DNA-Binding Proteins; E2F1 Transcription Factor; Female; Fluoresceins; Gene Expression Regulation, Neoplastic; Heterografts; Humans; Mice; Neoplasm Transplantation; Neoplasms; Nuclear Proteins; Tumor Cells, Cultured; Tumor Suppressor Protein p53

2014
Photo activation of HPPH encapsulated in "Pocket" liposomes triggers multiple drug release and tumor cell killing in mouse breast cancer xenografts.
    International journal of nanomedicine, 2015, Volume: 10

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Chlorophyll; Drug Liberation; Female; Fluoresceins; Humans; Lasers; Light; Liposomes; Luminescent Measurements; Mice; Mice, Nude; Photochemotherapy; Tissue Distribution; Xenograft Model Antitumor Assays

2015
Affibody-displaying bionanocapsules for specific drug delivery to HER2-expressing cancer cells.
    Bioorganic & medicinal chemistry letters, 2010, Oct-01, Volume: 20, Issue:19

    Topics: Breast Neoplasms; Cell Line, Tumor; Drug Carriers; Female; Fluoresceins; Hepatitis B Antigens; Humans; Nanoparticles; Receptor, ErbB-2; Recombinant Fusion Proteins

2010
Partially polymerized liposomes: stable against leakage yet capable of instantaneous release for remote controlled drug delivery.
    Nanotechnology, 2011, Apr-15, Volume: 22, Issue:15

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Aniline Compounds; Biological Availability; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Cryoelectron Microscopy; Delayed-Action Preparations; Diynes; Doxorubicin; Drug Stability; Endocytosis; Female; Fluoresceins; Glycine; Gold; Humans; Imino Acids; Lasers; Liposomes; Lysophospholipids; Metal Nanoparticles; Organotechnetium Compounds; Particle Size; Phosphatidylcholines; Phosphatidylethanolamines; Polymers; Surface Plasmon Resonance

2011
Reversal of doxorubicin-resistance by multifunctional nanoparticles in MCF-7/ADR cells.
    Journal of controlled release : official journal of the Controlled Release Society, 2011, Jun-30, Volume: 152, Issue:3

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Cell Line, Tumor; Cell Nucleus; Cell Survival; Cytoplasmic Granules; Cytosol; Doxorubicin; Drug Carriers; Drug Combinations; Drug Resistance, Neoplasm; Female; Fluoresceins; Fluorescent Dyes; Humans; Lactic Acid; Light; Molecular Structure; Nanoparticles; Particle Size; Photochemotherapy; Photosensitizing Agents; Polyesters; Polyethylene Glycols; Polymers; Porphyrins; Verapamil; Vitamin E

2011
Reduction-sensitive liposomes from a multifunctional lipid conjugate and natural phospholipids: reduction and release kinetics and cellular uptake.
    Langmuir : the ACS journal of surfaces and colloids, 2011, Sep-06, Volume: 27, Issue:17

    Topics: Biotin; Breast Neoplasms; Cell Line, Tumor; Disulfides; Doxorubicin; Drug Delivery Systems; Female; Fluoresceins; Humans; Kinetics; Lipids; Liposomes; Macrophages; Microscopy, Fluorescence; Molecular Structure; Oxidation-Reduction; Particle Size; Surface Properties; Tissue Distribution

2011
Targeting Her-2+ breast cancer cells with bleomycin immunoliposomes linked to LLO.
    Molecular pharmaceutics, 2012, Jul-02, Volume: 9, Issue:7

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bacterial Toxins; Bleomycin; Breast Neoplasms; Cell Line, Tumor; Cytoplasm; Endosomes; Female; Fluoresceins; Heat-Shock Proteins; Hemolysin Proteins; Humans; Liposomes; MCF-7 Cells; Receptor, ErbB-2; Trastuzumab

2012
Modulation of p-glycoprotein and breast cancer resistance protein by some prescribed corticosteroids.
    European journal of pharmacology, 2006, Feb-15, Volume: 531, Issue:1-3

    Topics: Adenosine Triphosphatases; Adrenal Cortex Hormones; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Beclomethasone; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Fluoresceins; Humans; Mitoxantrone; Mometasone Furoate; Neoplasm Proteins; Pregnadienediols; Pregnenediones

2006
The composition-dependent presence of free (micellar) alkylphospholipid in liposomal formulations of octadecyl-1,1-dimethyl-piperidino-4-yl-phosphate affects its cytotoxic activity in vitro.
    The Journal of membrane biology, 2001, Jul-01, Volume: 182, Issue:1

    Topics: Breast Neoplasms; Cell Division; Cell Survival; Chemistry, Pharmaceutical; Cholesterol; Ethanolamines; Female; Fluoresceins; Formazans; Humans; Liposomes; Lipoxygenase Inhibitors; Magnetic Resonance Spectroscopy; Micelles; Phenylpropionates; Polyethylene Glycols; Tetrazolium Salts; Tumor Cells, Cultured

2001